Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition

George C. Prendergast, Elizabeth Jaffee

Research output: Book/ReportBook

Abstract

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.

Original languageEnglish (US)
PublisherElsevier Inc.
Number of pages655
ISBN (Print)9780123942968
StatePublished - Jul 2013

Fingerprint

Immunotherapy
Growth
Neoplasms
Therapeutics
Combination Drug Therapy
Research Personnel
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Cancer Immunotherapy : Immune Suppression and Tumor Growth: Second Edition. / Prendergast, George C.; Jaffee, Elizabeth.

Elsevier Inc., 2013. 655 p.

Research output: Book/ReportBook

@book{eeeb0ff39ac6418d93f366019ba6bcdd,
title = "Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition",
abstract = "There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.",
author = "Prendergast, {George C.} and Elizabeth Jaffee",
year = "2013",
month = "7",
language = "English (US)",
isbn = "9780123942968",
publisher = "Elsevier Inc.",

}

TY - BOOK

T1 - Cancer Immunotherapy

T2 - Immune Suppression and Tumor Growth: Second Edition

AU - Prendergast, George C.

AU - Jaffee, Elizabeth

PY - 2013/7

Y1 - 2013/7

N2 - There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.

AB - There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.

UR - http://www.scopus.com/inward/record.url?scp=84902220783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902220783&partnerID=8YFLogxK

M3 - Book

AN - SCOPUS:84902220783

SN - 9780123942968

BT - Cancer Immunotherapy

PB - Elsevier Inc.

ER -